Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
McKinsey
Mallinckrodt
Colorcon
Medtronic

Last Updated: December 7, 2022

Didanosine - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for didanosine
US Patents:0
Tradenames:3
Applicants:6
NDAs:9
Drug Master File Entries: 8
Raw Ingredient (Bulk) Api Vendors: 115
Clinical Trials: 155
Patent Applications: 6,657
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in didanosine?didanosine excipients list
DailyMed Link:didanosine at DailyMed
Recent Clinical Trials for didanosine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Chang Gung Memorial HospitalPhase 1
TTY BiopharmPhase 1
Intergroupe Francophone de Cancerologie ThoraciquePhase 2

See all didanosine clinical trials

Medical Subject Heading (MeSH) Categories for didanosine
Paragraph IV (Patent) Challenges for DIDANOSINE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
VIDEX Capsules didanosine 75 mg 020155 1 2011-06-06
VIDEX EC Delayed-release Capsules didanosine 200 mg, 250 mg and 400 mg 021183 1 2004-06-01

US Patents and Regulatory Information for didanosine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo DIDANOSINE didanosine TABLET, FOR SUSPENSION;ORAL 077275-001 Aug 14, 2012 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Bristol Myers Squibb VIDEX didanosine FOR SOLUTION;ORAL 020155-005 Oct 9, 1991 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Bristol Myers Squibb VIDEX EC didanosine CAPSULE, DELAYED REL PELLETS;ORAL 021183-001 Oct 31, 2000 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Mylan Pharms Inc DIDANOSINE didanosine CAPSULE, DELAYED REL PELLETS;ORAL 090788-002 Apr 8, 2010 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Mylan Pharms Inc DIDANOSINE didanosine CAPSULE, DELAYED REL PELLETS;ORAL 090788-003 Apr 8, 2010 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Barr DIDANOSINE didanosine CAPSULE, DELAYED REL PELLETS;ORAL 077167-003 Dec 3, 2004 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Aurobindo Pharma DIDANOSINE didanosine CAPSULE, DELAYED REL PELLETS;ORAL 090094-001 Sep 24, 2008 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for didanosine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb VIDEX didanosine TABLET, CHEWABLE;ORAL 020154-003 Oct 9, 1991 See Plans and Pricing See Plans and Pricing
Bristol Myers Squibb VIDEX didanosine FOR SOLUTION;ORAL 020155-006 Oct 9, 1991 See Plans and Pricing See Plans and Pricing
Bristol Myers Squibb VIDEX didanosine TABLET, CHEWABLE;ORAL 020154-005 Oct 9, 1991 See Plans and Pricing See Plans and Pricing
Bristol Myers Squibb VIDEX didanosine TABLET, CHEWABLE;ORAL 020154-002 Oct 9, 1991 See Plans and Pricing See Plans and Pricing
Bristol VIDEX didanosine FOR SOLUTION;ORAL 020156-001 Oct 9, 1991 See Plans and Pricing See Plans and Pricing
Bristol Myers Squibb VIDEX didanosine FOR SOLUTION;ORAL 020155-006 Oct 9, 1991 See Plans and Pricing See Plans and Pricing
Bristol Myers Squibb VIDEX didanosine FOR SOLUTION;ORAL 020155-004 Oct 9, 1991 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Boehringer Ingelheim
Johnson and Johnson
Merck
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.